{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:36:13Z","timestamp":1792067773359,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,6,4]],"date-time":"2009-06-04T00:00:00Z","timestamp":1244073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2334-9-83","type":"journal-article","created":{"date-parts":[[2009,6,4]],"date-time":"2009-06-04T18:13:12Z","timestamp":1244139192000},"source":"Crossref","is-referenced-by-count":58,"title":["Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options"],"prefix":"10.1186","volume":"9","author":[{"given":"Silvia","family":"Natoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Favaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bergamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Piero","family":"Testore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Minelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Bossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Casapulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Broglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Beltrame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Cerretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Leonardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,4]]},"reference":[{"issue":"3B","key":"848_CR1","doi-asserted-by":"publisher","first-page":"72S","DOI":"10.1016\/0002-9343(91)90346-Y","volume":"91","author":"DR Schaberg","year":"1991","unstructured":"Schaberg DR, Culver DH, Gaynes RP: Major trends in the microbial etiology of nosocomial infection. Am J med. 1991, 91 (3B): 72S-75S. 10.1016\/0002-9343(91)90346-Y.","journal-title":"Am J med"},{"issue":"3B","key":"848_CR2","doi-asserted-by":"publisher","first-page":"86S","DOI":"10.1016\/0002-9343(91)90349-3","volume":"91","author":"SN Banerjee","year":"1991","unstructured":"Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Tolson J, Henderson T, Martone VJ: Secular trends in nosocomial primary bloodstream infections in the United States, 1980\u20131989. National Nosocomial Infections Surveillance System. Am J Med. 1991, 91 (3B): 86S-89S. 10.1016\/0002-9343(91)90349-3.","journal-title":"Am J Med"},{"key":"848_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/CMR.6.4.428","volume":"6","author":"TG Emory","year":"1993","unstructured":"Emory TG, Gaynes RP: An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993, 6: 428-442.","journal-title":"Clin Microbiol Rev"},{"key":"848_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/jac\/29.4.459","volume":"29","author":"R Cunningham","year":"1992","unstructured":"Cunningham R: Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus. J antimicrob Chemother. 1992, 29: 459-66. 10.1093\/jac\/29.4.459.","journal-title":"J antimicrob Chemother"},{"key":"848_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/jac\/29.4.461","volume":"29","author":"F Menichetti","year":"1992","unstructured":"Menichetti F: Gram-positive infections in neutropenic patients: glycopeptide antibiotics choice. J Antimicrob Chemother. 1992, 29: 461-3. 10.1093\/jac\/29.4.461.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"848_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2334-5-31","volume":"5","author":"Y Nakipoglu","year":"2005","unstructured":"Nakipoglu Y, Derbentli S, Cagatay AA, Katranci H: Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital. BMC Infect Dis. 2005, 5 (1): 31-10.1186\/1471-2334-5-31.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"848_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s101560100026","volume":"7","author":"Y Tabe","year":"2001","unstructured":"Tabe Y, Nakamura A, Igari J: Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates. J Infect Chemother. 2001, 7 (3): 142-7. 10.1007\/s101560100026.","journal-title":"J Infect Chemother"},{"issue":"3","key":"848_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1086\/501605","volume":"20","author":"DO Garrett","year":"1999","unstructured":"Garrett DO, Jochimensen E, Murfitt K, Hill B, McAllister S, Nelson P, Spera RV, Sall RK, Tenover FC, Johnston J, Zimmer B, Jarvis WR: The Emergence of decreased suscepitibility to vancomycin in Staphilococcus Epidermidis. Infect Control Hosp Epidemiol. 1999, 20 (3): 167-70. 10.1086\/501605.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"848_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/infdis\/154.2.349","volume":"154","author":"VE Del Bene","year":"1986","unstructured":"Del Bene VE, Jhon JF, Twitty JA, Lewis JW: Antistaphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance. J Infect Dis. 1986, 154: 349-52.","journal-title":"J Infect Dis"},{"issue":"8575-6","key":"848_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","volume":"1","author":"AH Uttley","year":"1988","unstructured":"Uttley AH, Collins CH, Naidoo J, George RC: Vancomycin-resistant enterococci. Lancet. 1988, 1 (8575-6): 57-58. 10.1016\/S0140-6736(88)91037-9.","journal-title":"Lancet"},{"key":"848_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJM198807213190307","volume":"319","author":"R Leclercq","year":"1988","unstructured":"Leclercq R, merlot E, Duval J, Courvalin P: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988, 319: 157-161.","journal-title":"N Engl J Med"},{"key":"848_CR12","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","volume":"350","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I: Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistantt to vancomycin. Lancet. 1997, 350: 1670-1673. 10.1016\/S0140-6736(97)07324-8.","journal-title":"Lancet"},{"issue":"7","key":"848_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJM199902183400701","volume":"340","author":"TL Smith","year":"1999","unstructured":"Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR: Emergence of vancomycin resistance in staphylococcus aureus. N Engl J Med. 1999, 340 (7): 493-501. 10.1056\/NEJM199902183400701.","journal-title":"N Engl J Med"},{"issue":"2","key":"848_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2006.07.007","volume":"57","author":"D Webster","year":"2007","unstructured":"Webster D, Rennie RP, Brosnikoff CL, Chui L, Brown C: Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada. Diagn Microbiol Infect Dis. 2007, 57 (2): 177-81. 10.1016\/j.diagmicrobio.2006.07.007.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"848_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jac\/44.5.675","volume":"44","author":"RA Howe","year":"1999","unstructured":"Howe RA, Wootton M, Walsh TR, Bennett PM, MacGowan AP: Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus. J Antimicrob Chemother. 1999, 44 (5): 675-8. 10.1093\/jac\/44.5.675.","journal-title":"J Antimicrob Chemother"},{"key":"848_CR16","volume-title":"CLSI document M100-S18","author":"CLSI","year":"2008","unstructured":"CLSI: Performance Standards for antimicrobial susceptibility testing; Eighteenth Informational Supplement. CLSI document M100-S18. 2008, Wayne, PA: Clinical and Laboratory Standards Institute"},{"key":"848_CR17","unstructured":"Laboratory Detection of Vancomycin-Intermediate\/Resistant Staphylococcus aureus (VISA\/VRSA). CDC Updated. 2006, [\n                    http:\/\/www.cdc.gov\/ncidod\/dhqp\/ar_visavrsa_labFAQ.html\n                    \n                  ]"},{"key":"848_CR18","volume-title":"Numerical Taxonomy: Principles and Practice of numerical taxonomy","author":"PHA Sneath","year":"1973","unstructured":"Sneath PHA, Sokal RR: Numerical Taxonomy: Principles and Practice of numerical taxonomy. 1973, San Francisco, WH Freeman"},{"issue":"8","key":"848_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2307\/30141781","volume":"19","author":"MJ Struelens","year":"1998","unstructured":"Struelens MJ, De Gheldre Y, Deplano A: Comparative and library epidemiological typing systems: outbreak investigations versus surveillance systems. Infect Control Hosp Epidemiol. 1998, 19 (8): 565-9.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"848_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CMR.15.3.430-438.2002","volume":"15","author":"A Srinivasan","year":"2002","unstructured":"Srinivasan A, Dick JD, Perl TM: Vancomycin resistance in staphylococci. Clin Microbiol Rev. 2002, 15 (3): 430-8. 10.1128\/CMR.15.3.430-438.2002.","journal-title":"Clin Microbiol Rev"},{"issue":"15","key":"848_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1056\/NEJM198704093161507","volume":"316","author":"RS Schwalbe","year":"1987","unstructured":"Schwalbe RS, Stapleton JT, Gilligan Ph: Emergence of vancomycin-resistance in coagulase-negative staphylococci. N Engl J Med. 1987, 316 (15): 927-931.","journal-title":"N Engl J Med"},{"key":"848_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s100960000299","volume":"19","author":"F Biavasco","year":"2000","unstructured":"Biavasco F, Vignaroli C, Varaldo PE: Glycopeptide Resistance in Coagulase-Negative Staphylococci. Eur J Clin Microbiol Infect Dis. 2000, 19: 403-417. 10.1007\/s100960000299.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"848_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1086\/501605","volume":"20","author":"Denise O Garret","year":"1999","unstructured":"Garret Denise, Jochimsen Elise, Murfitt Kate, Hill Berta, McAllinster Sigrid, Nelson Pat, Spera Richard, Small Richard, Tenover Fred, Johnston Judy, Zimmer Barbara, Jarvis William: The Emergence of Decreased Susceptibility to Vancomycin in Staphylococcus Epidermidis. Infection Control and Hospital Epidemiology. 1999, 20 (3): 167-170. 10.1086\/501605.","journal-title":"Infection Control and Hospital Epidemiology"},{"issue":"Suppl 2","key":"848_CR24","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1086\/320184","volume":"32","author":"DJ Diekema","year":"2001","unstructured":"Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, SENTRY Partcipants Group: Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997\u20131999. Clin Infect Dis. 2001, 32 (Suppl 2): S114-32. 10.1086\/320184.","journal-title":"Clin Infect Dis"},{"key":"848_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0732-8893(99)00034-6","volume":"34","author":"DA Alamo","year":"1999","unstructured":"Alamo DA, Cereda FR, Tosin I, Miranda AE, Sader SH: Antimicrobial susceptibility of coagulase-negative Staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Diagn Microbiol Infect Dis. 1999, 34: 185-91. 10.1016\/S0732-8893(99)00034-6.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"848_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s101560100026","volume":"7","author":"T Yoko","year":"2001","unstructured":"Yoko T, Ayaco N, Jun I: Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates. J Infect Chemoter. 2001, 7: 142-147. 10.1007\/s101560100026.","journal-title":"J Infect Chemoter"},{"key":"848_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijantimicag.2005.11.013","volume":"27","author":"AP Ferreira Nunes","year":"2006","unstructured":"Ferreira Nunes AP, Teixeira Martins L\u00facia, Iorio Lopes Pontes Nat\u00e1lia, Bastos Calleg\u00e1rio Reis Carla, Leila de Sousa Fonseca, Souto-Padr\u00f3n Tha\u00eds, dos Santos Regina Netto K\u00e1tia: Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterization of glycopeptides susceptibility profiles and cell wall thickening. International Journal of Antimicrobial Agents. 2006, 27: 307-315. 10.1016\/j.ijantimicag.2005.11.013.","journal-title":"International Journal of Antimicrobial Agents"},{"key":"848_CR28","unstructured":"FDA ALERT 3\/16\/2007. [\n                    http:\/\/www.fda.gov\/medwatch\/safety\/2007\/safety07.htm#Zyvox\n                    \n                  ]"},{"key":"848_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10096-007-0272-x","volume":"26","author":"J G\u00f2mez","year":"2007","unstructured":"G\u00f2mez J, Garc\u00eca-Vazquez E, Ba\u00f1os R, Canteras M, Ruiz J, Ba\u00f1os V, Herrero JA, Vald\u00e9s M: Predictors of mortality in patients with methicillin-resistant staphilococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis. 2007, 26: 239-245. 10.1007\/s10096-007-0272-x.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"848_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11096-005-1638-8","volume":"27","author":"S Grau","year":"2005","unstructured":"Grau S, Mateu-de Antonio J, Soto J, Mar\u00edn-Casino M, Salas E: Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by Gram-positive microorganisms. Pharm World Sci. 2005, 27 (6): 459-64. 10.1007\/s11096-005-1638-8.","journal-title":"Pharm World Sci"},{"issue":"7","key":"848_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"335","author":"VG Fowler","year":"2006","unstructured":"Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fatkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE: Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006, 335 (7): 653-665. 10.1056\/NEJMoa053783.","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-9-83\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-83","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T06:46:15Z","timestamp":1548139575000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-9-83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-9-83","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,4]]},"article-number":"83"}}